Successful rescue therapy with eculizumab for probable tislelizumab-related MMM overlap syndrome with dual positivity for anti-acetylcholine receptor and anti-titin antibodies: a case report and literature review - Top-Institutions - MDSpire

Successful rescue therapy with eculizumab for probable tislelizumab-related MMM overlap syndrome with dual positivity for anti-acetylcholine receptor and anti-titin antibodies: a case report and literature review

  • By

  • Yi-Xiao Li

  • Yan-Lei Hao

  • June 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Immunology
    • Neurology

  • #2

    The Johns Hopkins Hospital
    The Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Immunology
    • Neurology

  • #3

    Emory University Hospital
    Emory University Hospital

    Atlanta, Georgia

    Key Differentiators

    • Immunology
    • Neurology

  • #4

    Charité Berlin
    Charité Berlin

    Berlin, Germany

    Key Differentiators

    • Immunology

  • #5

    Heinrich Heine University Duesseldorf
    Heinrich Heine University Duesseldorf

    Düsseldorf, Germany

    Key Differentiators

    • Immunology

Original Source(s)

Successful rescue therapy with eculizumab for probable tislelizumab-related MMM overlap syndrome with dual positivity for anti-acetylcholine receptor and anti-titin antibodies: a case report and literature review

  • by Yi-Xiao Li, Yan-Lei Hao

  • June 10, 2026

Related Content

Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma

Development and validation of an interpretable machine learning model for predicting 5-year recurrence in breast cancer

Long-read sequencing for cancer liquid biopsy: advancing precision oncology